Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Sarah A Holstein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9342-5635; OpenAlex author ID A5005732386; NIH RePORTER profile ID 9765464. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 1

  1. Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41388-019-0794-6↗

Grants 1

  1. Targets, Modulators and Delivery Program P30CA036727↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer D. Black · 1 shared grant, 2026 · strength 0.86
  2. Kenneth H. Cowan · 1 shared grant, 2026 · strength 0.86
  3. Jane L. Meza · 1 shared grant, 2026 · strength 0.86
  4. Kamiya Mehla · 1 shared paper, 2019 · strength 0.09
  5. Lynette M. Smith · 1 shared paper, 2019 · strength 0.09
  6. Daryl J. Murry · 1 shared paper, 2019 · strength 0.09
  7. Staci L. Haney · 1 shared paper, 2019 · strength 0.09
  8. Michael Anthony Hollingsworth · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.